Correction to: Cystic Fibrosis Revisited - A Review Study

Title:Correction to: Cystic Fibrosis Revisited - A Review Study

Volume: 17 Issue: 5

Author(s): Blanka Klimova, Kamil Kuca*, Michal Novotny and Petra Maresova

Affiliation:

• Biomedical Research Centrum, University Hospital Hradec Kralove, Hradec Kralove,Czech Republic

Abstract: In the following article, the author reported an error in the abstract’s result section [1].

The results section of the abstract has been changed as follows:

Results: The main benefits (e.g., specialized centres for the treatment of CF exist or a new breakthrough in the gene therapy of CF has been made) and limitations (e.g., comorbidity of CF, lifelong and costly treatment, or adverse impact on patient’s and caregiver’s quality of life) in the treatment of CF are highlighted.

The original results section of the abstract was published as:

Results: The main benefits (e.g., specialized centres for the treatment of CF exist or a new breakthrough in the gene therapy of CF has been made) and limitations (e.g., comorbidity of CF, lifelong and costly treatment, or adverse impact on patient’s and caregiver’s quality of life) in the treatment of narcolepsy are highlighted.

The original article can be found online at 10.2174/1573406412666160608113235

Cite this article as:

Klimova Blanka , Kuca Kamil *, Novotny Michal and Maresova Petra , Correction to: Cystic Fibrosis Revisited - A Review Study, Medicinal Chemistry 2021; 17 (5) . https://dx.doi.org/10.2174/157340641705210524122637